Aurora A kinase inhibition and treatment of neuroendocrine prostate cancer

A research team in Los Angeles has demonstrated that a protein produced by a cancer gene (the MYCN gene) leads to the development of the often deadly, late-stage form of prostate cancer called neuroendocrine prostate cancer. … READ MORE …